An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials P. Conaghan, V. Strand, D. Hunter, V.B. Kraus, F. Berenbaum, N.P. Katz, J. Lufkin, J.R. Johnson, S. Kelley, N. Bodick Osteoarthritis and Cartilage Volume 25, Pages S432-S433 (April 2017) DOI: 10.1016/j.joca.2017.02.747 Copyright © 2017 Terms and Conditions
Figure 1 Proportions of OMERACT-OARSI “Strict” Responders (Pooled analyses, FAS). Osteoarthritis and Cartilage 2017 25, S432-S433DOI: (10.1016/j.joca.2017.02.747) Copyright © 2017 Terms and Conditions